CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 52 filers reported holding CTI BIOPHARMA CORP in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $29,831,030 | -29.7% | 7,102,626 | +0.6% | 0.00% | 0.0% |
| Q4 2022 | $42,432,518 | +10.5% | 7,060,319 | +7.0% | 0.00% | 0.0% |
| Q3 2022 | $38,405,000 | +9.2% | 6,598,773 | +12.0% | 0.00% | 0.0% |
| Q2 2022 | $35,170,000 | +320.3% | 5,890,969 | +228.8% | 0.00% | – |
| Q1 2022 | $8,367,000 | +87.5% | 1,791,693 | -0.4% | 0.00% | – |
| Q4 2021 | $4,462,000 | +68.9% | 1,798,830 | +100.9% | 0.00% | – |
| Q3 2021 | $2,642,000 | +17.7% | 895,391 | -0.2% | 0.00% | – |
| Q2 2021 | $2,244,000 | -17.1% | 897,051 | -3.6% | 0.00% | – |
| Q1 2021 | $2,708,000 | -7.6% | 930,610 | +2.3% | 0.00% | – |
| Q4 2020 | $2,931,000 | +46.9% | 910,037 | -2.0% | 0.00% | – |
| Q3 2020 | $1,995,000 | +84.7% | 928,279 | -0.3% | 0.00% | – |
| Q2 2020 | $1,080,000 | +55.8% | 931,466 | +23.6% | 0.00% | – |
| Q1 2020 | $693,000 | -28.3% | 753,316 | +23.2% | 0.00% | – |
| Q4 2019 | $966,000 | +237.8% | 611,506 | +79.4% | 0.00% | – |
| Q3 2019 | $286,000 | -2.1% | 340,951 | +0.2% | 0.00% | – |
| Q2 2019 | $292,000 | -89.2% | 340,125 | -87.8% | 0.00% | – |
| Q1 2019 | $2,711,000 | +27.7% | 2,794,715 | -3.4% | 0.00% | – |
| Q4 2018 | $2,123,000 | -65.9% | 2,893,856 | +0.3% | 0.00% | – |
| Q3 2018 | $6,230,000 | -55.4% | 2,884,361 | +2.9% | 0.00% | -100.0% |
| Q2 2018 | $13,958,000 | +725.4% | 2,803,182 | +546.2% | 0.00% | – |
| Q1 2018 | $1,691,000 | +52.1% | 433,784 | +4.5% | 0.00% | – |
| Q4 2017 | $1,112,000 | -14.5% | 415,118 | +1.9% | 0.00% | – |
| Q3 2017 | $1,300,000 | +1.5% | 407,532 | +5.4% | 0.00% | – |
| Q2 2017 | $1,281,000 | -14.0% | 386,769 | +9.0% | 0.00% | – |
| Q1 2017 | $1,490,000 | – | 354,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|